Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
about
Calretinin and Neuropeptide Y interneurons are differentially altered in the motor cortex of the SOD1G93A mouse model of ALS.Synapse Dysfunction of Layer V Pyramidal Neurons Precedes Neurodegeneration in a Mouse Model of TDP-43 Proteinopathies.Increased cerebral functional connectivity in ALS: A resting-state magnetoencephalography study.Reduced Excitability and Increased Neurite Complexity of Cortical Interneurons in a Familial Mouse Model of Amyotrophic Lateral Sclerosis
P2860
Inhibitory dysfunction in amyotrophic lateral sclerosis: future therapeutic opportunities.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Inhibitory dysfunction in amyo ...... ure therapeutic opportunities.
@en
type
label
Inhibitory dysfunction in amyo ...... ure therapeutic opportunities.
@en
prefLabel
Inhibitory dysfunction in amyo ...... ure therapeutic opportunities.
@en
P2093
P2860
P50
P356
P1476
Inhibitory dysfunction in amyo ...... ure therapeutic opportunities.
@en
P2093
Catherine Blizzard
Rosemary Clark
Tracey Dickson
P2860
P304
P356
10.2217/NMT.15.49
P577
2015-11-30T00:00:00Z